David Wambeke Net Worth & Insider Trades
David Wambeke - Chief Business Officer, Diamedica Therapeutics Inc
What is David Wambeke's Net Worth?
The current estimated net worth of Diamedica Therapeutics Inc's Chief Business Officer, David Wambeke, is estimated to be about $801.56K . David Wambeke owns about 468,750 units of Diamedica Therapeutics Inc common stock. Recently at Diamedica Therapeutics Inc, David Wambeke has sold an estimated value of $0 worth.
What is David Wambeke's Past Insider Trading?
David Wambeke's largest purchase order was 468,750 units , worth over $750K on April 11, 2023. In total, David Wambeke has made about 1 transaction recently at Diamedica Therapeutics Inc. David Wambeke usually trades in April, with the busiest year in 2023.
David Wambeke
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is David Wambeke's' Mailing Address?
- Mailing address is 301 Carlson Parkway, Suite 210 Minneapolis MN 55305 MN
Diamedica Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Rick Pauls | 2020 | $455,013 | - | $190,624 | $217,716 | $14,850 | $878,203 |
| Rick Pauls | 2019 | $420,000 | - | $890,736 | $178,000 | $14,650 | $733,707 |
| Scott Kellen | 2020 | $276,075 | - | $119,140 | $79,238 | $14,850 | $489,303 |
| Scott Kellen | 2019 | $262,500 | - | $336,557 | $64,800 | $13,950 | $677,807 |
| Harry Alcorn, Jr., Pharm.D. | 2020 | $291,413 | - | $119,140 | $83,662 | $14,850 | $509,065 |
| Harry Alcorn, Jr., Pharm.D. | 2019 | $273,750 | - | $421,750 | $68,400 | $14,400 | $778,300 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm
What are Diamedica Therapeutics Inc's Past Insider Trades?
Diamedica Therapeutics Inc's most recent insider trade came on April 11, 2023 by David Wambeke who bought 468,750 units worth $750K . In the last 5 years, insiders at Diamedica Therapeutics Inc have sold an estimated value of $3.53M and bought an estimated value of $6.28M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Michael Randall Giuffre, Director, Richard Pilnik, Director, and Scott Kellen, CFO and Secretary .
DiaMedica Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||